CANGENE CORPORATION

Monoclonal and Polyclonal Antibody Based Pharmaceutical Products from Human and Animal Sources for Use in Treating Infectious Diseases, Blood Disorders and Immunological Diseases; and Recombinant Protein Based Pharmaceutical Products for Treating Hormone Deficiency, Radiation Exposure and Oncology Related Diseases